American Well Corp (AMWL.US)

10-Year Study

AMWL.US · Healthcare · Common Stock

About American Well Corp (AMWL.US)

Healthcare

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care....

Source: EODHD Financial Datasets
Fundamentals updated: Jul 31, 2026

Fundamental Snapshot

American Well Corp (AMWL.US) reports a gross margin of 53.8% and an operating margin of -23.6%. Revenue changed -17.9% year-over-year while EPS changed +42.7%. Financially, its return on equity is -31.8%, current ratio stands at 3.09x, debt-to-equity ratio is 0.02x.

Executive Summary: American Well Corp has compounded at -49.7% annually over the last 10 years, with a maximum drawdown of 99.4% and an annualized volatility of 97.0%.

1Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
+62.4%
3Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
-24.0%
5Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
-44.3%
10Y CAGRCAGRCompound Annual Growth Rate — the annualized rate of return over a period, accounting for compounding.Click for full definition →
-49.7%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

View full price history data
DateValue
2020-09-01$10,000
2020-10-01$8,708
2020-11-01$8,954
2020-12-01$8,546
2021-01-01$11,947
2021-02-01$8,256
2021-03-01$5,860
2021-04-01$5,192
2021-05-01$4,200
2021-06-01$4,244
2021-07-01$3,930
2021-08-01$3,613
2021-09-01$3,074
2021-10-01$3,036
2021-11-01$2,193
2021-12-01$2,038
2022-01-01$1,596
2022-02-01$1,427
2022-03-01$1,420
2022-04-01$1,056
2022-05-01$1,275
2022-06-01$1,457
2022-07-01$1,316
2022-08-01$1,535
2022-09-01$1,211
2022-10-01$1,380
2022-11-01$1,231
2022-12-01$955
2023-01-01$1,339
2023-02-01$941
2023-03-01$796
2023-04-01$739
2023-05-01$746
2023-06-01$709
2023-07-01$827
2023-08-01$479
2023-09-01$395
2023-10-01$395
2023-11-01$428
2023-12-01$503
2024-01-01$354
2024-02-01$364
2024-03-01$274
2024-04-01$172
2024-05-01$144
2024-06-01$110
2024-07-01$135
2024-08-01$140
2024-09-01$160
2024-10-01$155
2024-11-01$161
2024-12-01$122
2025-01-01$182
2025-02-01$168
2025-03-01$133
2025-04-01$124
2025-05-01$114
2025-06-01$150
2025-07-01$124
2025-08-01$116
2025-09-01$104
2025-10-01$88
2025-11-01$71
2025-12-01$83
2026-01-01$77
2026-02-01$96
2026-03-01$89
2026-04-01$107
2026-05-01$166
2026-06-01$154
2026-07-01$181
Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
99.4%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
-0.57
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
-1.16
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
70.3%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · +118.9%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2021 · -76.2%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
17%

Annual Returns

View full annual returns data
YearReturn
2021-76.2%
2022-53.1%
2023-47.3%
2024-75.7%
2025-32.3%
2026118.9%

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-7.325.3-7.720.255.5-7.217.9118.9%
202548.7-7.6-20.9-7.0-8.031.9-17.3-6.1-10.9-15.1-19.016.1-32.3%
2024-29.52.9-24.9-37.1-16.3-23.923.23.614.2-3.44.5-24.2-75.7%
202340.3-29.7-15.4-7.20.9-5.016.7-42.0-17.60.08.517.3-47.3%
2022-21.7-10.6-0.5-25.720.814.3-9.716.7-21.113.9-10.8-22.5-53.1%
202139.8-30.9-29.0-11.4-19.11.0-7.4-8.1-14.9-1.2-27.8-7.1-76.2%
2020-12.92.8-4.6-14.5%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
97.0%
View full factor risk breakdown
FactorRisk Exposure
VTI.US-4.5%
VEA.US-2.2%
VWO.US-0.2%
QQQ.US2.8%
VTV.US-3.1%
IJR.US7.8%
QUAL.US9.8%
SHV.US50.8%
TLT.US5.3%
LQD.US2.0%
HYG.US-1.2%
GLD.US-0.0%
USO.US0.3%
VNQ.US3.0%
BTC-USD.CC-0.3%
CPER.US0.9%
VIX.INDX0.4%
UUP.US2.5%
TIP.US4.3%
Idiosyncratic21.7%

American Well Corp Business Fundamentals

Reported valuation multiples, trailing margins, YoY growth, and balance-sheet liquidity.

Valuation Multiples

Price-to-Sales (P/S)
0.76x
22nd pct of 226 Healthcare peers · median 2.73x
Price-to-Book (P/B)
0.82x
7th pct of 229 Healthcare peers · median 3.44x

Profitability & Margins

Gross Margin (TTM)
53.8%
46th pct of 183 Healthcare peers · median 57.1%
Operating Margin (TTM)
-23.6%
28th pct of 216 Healthcare peers · median 0.0%
Return on Equity (ROE)
-31.8%
43rd pct of 228 Healthcare peers · median -16.1%

Year-over-Year Growth

Revenue Growth (YoY)
-17.9%
11th pct of 229 Healthcare peers · median +5.0%
EPS Growth (YoY)
+42.7%
68th pct of 201 Healthcare peers · median +14.1%

Financial Position

Debt-to-Equity
0.02x
19th pct of 188 Healthcare peers · median 0.23x
Current Ratio
3.09x
53rd pct of 220 Healthcare peers · median 2.70x

Market Sentiment

Short Squeeze RiskLow

Dividend & Income Analysisi10-Year historical income simulation on a $10,000 initial investment, cumulative dividend income generated, average yield on cost, and annual payout table.

Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators: distance from 50/200-Day SMA, 52-Week High proximity, Golden Cross trend signal, RSI momentum gauge, Fibonacci retracement levels, and Beta (market sensitivity).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+12.6%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+70.1%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
18.7% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.70
Market sensitivity coefficient
Trend SignalGolden Cross & Death CrossTechnical chart patterns that occur when a short-term moving average crosses over a long-term moving average.Click for full definition →
✦ Golden Cross
Bullish — 50 SMA above 200 SMA
RSI (14-Day)Relative Strength Index (RSI)A momentum oscillator that measures the speed and change of price movements to identify overbought or oversold conditions.Click for full definition →
48
OversoldNeutralOverbought
Neutral
Fibonacci LevelsFibonacci RetracementTechnical levels based on mathematical ratios that indicate potential support and resistance areas.Click for full definition →
38.2% retracement+11.7%
50.0% retracement+26.4%
61.8% retracement+45.5%
% distance of current price from each 52-week Fibonacci support level.

In-Depth Analysis

AMWL.US — 10-Year Return & Risk Profile

American Well Corp (AMWL.US) has delivered negative annualized growth of 49.7% over the last 10 years. A $10,000 investment at the start of the period would have grown to approximately $10, representing a total return of 100%. Over this period, AMWL.US generated positive annual returns in 2 out of 10 calendar years (17%).

The best single calendar year for AMWL.US was 2026, with a return of +118.9%. The worst year was 2021, when the asset declined 76.2%. This spread between best and worst year is a useful indicator of the range of outcomes an investor might have experienced in a given 12-month window.

The asset's Sharpe ratio of -0.57 is considered poor on a risk-adjusted basis. The Sharpe ratio measures return earned above the risk-free rate per unit of total volatility — a higher reading indicates more efficient return generation relative to the risk taken. Investors focused on risk-adjusted outcomes should weigh this figure alongside absolute CAGR when making allocation decisions.

AMWL.US — Drawdown, Volatility & Downside Risk

AMWL.US's annualized volatility of 70.3% is classified as high relative to the long-run US equity benchmark of approximately 15%. This above-average volatility means investors in AMWL.US have historically experienced larger day-to-day price swings than the broader market, which requires a higher tolerance for short-term portfolio fluctuations.

The asset's maximum peak-to-trough decline over the study period was 99.4% — a catastrophic peak-to-trough decline. Drawdown magnitude is a critical consideration for investors who may need to liquidate positions during market stress, as a larger decline requires proportionally greater subsequent gains to recover to the prior peak. A 99% drawdown, for example, requires a 16642% gain just to break even.

When evaluating AMWL.US for inclusion in a diversified US portfolio, it is important to note that historical volatility and drawdown metrics are backward-looking. They capture the risk environment of the past 10 years, which included the COVID-19 market crash (2020), the 2022 Federal Reserve rate hike cycle, and various geopolitical disruptions. Future risk may differ materially, particularly in response to structural changes in US monetary policy, sector regulation, or macroeconomic regime shifts.

AMWL.US — Macroeconomic Factor Risk Exposure

The macroeconomic factor model attributes 50.8% of AMWL.US's return variance to Short-Term Interest Rates. This means that when Short-Term Interest Rates rises or falls sharply, AMWL.US tends to move in the same direction with meaningful magnitude. Investors who already hold significant exposure to this factor — through other funds or direct equity positions — should be aware of this concentration when sizing their AMWL.US allocation.

The second-largest macro driver is US Quality Factor, contributing 9.8% of variance. 21.7% of AMWL.US's risk is attributable to idiosyncratic, stock-specific factors that are uncorrelated with the broader macro drivers. A higher idiosyncratic share generally indicates that the fund's performance is more dependent on the security selection or holdings composition of the individual underlying assets, rather than broad market forces.

For US investors building a diversified multi-asset portfolio, understanding AMWL.US's factor exposures helps assess its marginal contribution to overall portfolio risk. Adding AMWL.US alongside assets with low correlation to Short-Term Interest Rates — such as US Treasury bonds, commodities, or assets with significant developed-market ex-US exposure — can reduce the overall portfolio's sensitivity to any single macroeconomic theme.

Compare this AssetiRun a head-to-head backtest and risk analysis against similar assets.

Frequently Asked Questions & Methodology

Is American Well Corp a high-risk investment?

American Well Corp (AMWL.US) has an annualized volatility of 97.0% and experienced a maximum drawdown of 99.4% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of AMWL.US?

Over the past 10 years, AMWL.US has generated a Compound Annual Growth Rate (CAGR) of -49.7%. A $10,000 investment would have grown to approximately $10. It has had a positive return in 17% of calendar years.

What is AMWL.US's Sharpe ratio?

AMWL.US has a Sharpe ratio of -0.57 and a Sortino ratio of -1.16 over the 10-year period. The Sharpe ratio measures risk-adjusted return — how much excess return is earned per unit of volatility. A reading below 1.0 suggests investors were not fully compensated on a risk-adjusted basis.

What is AMWL.US's dividend yield?

AMWL.US does not pay a meaningful dividend. Its returns are driven primarily by price appreciation. Investors seeking regular income may wish to consider dividend-focused alternatives.

Is AMWL.US above its 200-day moving average?

AMWL.US is currently above its 200-day moving average by 70.1%. The current trend signal is: Bullish — 50 SMA above 200 SMA. The 200-day SMA is a widely used long-term trend filter — assets trading above it tend to exhibit positive price momentum.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on American Well Corp

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest